Loading clinical trials...
Loading clinical trials...
Lyophilized Fecal Microbiome Transfer for Primary Clostridioides Difficile Infection (DONATE Study): a Multicenter Randomized Controlled Trial
Conditions
Interventions
Lyophilized fecal microbiome transfer
Vancomycin
Locations
6
Canada
University of Alberta
Edmonton, Canada
University of Debrecen
Debrecen, Hungary
Rambam Health Care Campus
Haifa, Israel
Gemelly institute Policlinico Universitario Fondazione Agostino Gemelli
Rome, Italy
Hospital of Lithuania University of Health Sciences Kauno klinikos
Kaunas, Lithuania
Imperial College of London
London, United Kingdom
Start Date
November 15, 2023
Primary Completion Date
November 1, 2025
Completion Date
March 1, 2026
Last Updated
April 10, 2024
NCT06370884
NCT06237452
NCT05739825
NCT06306014
NCT07374094
NCT07250724
Lead Sponsor
Rambam Health Care Campus
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions